The plan would need to be supported by the incoming Trump administration, which has vowed to cut costs across the federal ...
About 42% of U.S. adults are obese, the CDC says. GLP-1 medications have changed the picture for people hoping to reduce ...
The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.
The proposal would let patients get Wegovy, Ozempic and related drugs for obesity, which Medicare and Medicaid does not cover ...
Millions of obese Americans would be eligible to have popular weight-loss drugs like Wegovy or Ozempic covered by Medicare or ...
Weight loss drugs like Wegovy, Zepbound and Ozempic would be covered by Medicare and Medicaid under a Biden administration ...
Medicare and Medicaid would be required to cover weight loss drug prescriptions for millions of obese Americans under plans ...
The Biden administration proposed expanding coverage of weight loss medication to Medicaid and Medicare recipients. RFK Jr.
The new rule would expand access to the drugs for 3.4 million Americans who use Medicare and another 4 million people ...